XML 20 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Preferred Stock
Series B convertible preferred stock
Preferred Stock
Series C convertible preferred stock
Preferred Stock
Series C-1 convertible preferred stock
Preferred Stock
Series D convertible preferred stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Stockholders' Equity, Beginning Balance at Dec. 31, 2015 $ (35,179) $ 28,220 $ 6,452 $ 2,156 $ 40,688 $ 3 $ 15,482 $ 0 $ (50,664)
Shares, Outstanding, Beginning Balance at Dec. 31, 2015   3,963,000 1,593,000 474,000 5,491,000 2,630,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued under employee stock plans 31           31    
Shares issued under employee stock plans (in shares)           23,000      
Repurchase of shares $ (1)           (1)    
Repurchase of shares (in shares) (1,457)         (2,000)      
Stock-based compensation $ 1,160           1,160    
Net loss (4,259)               (4,259)
Stockholders' Equity, Ending Balance at Dec. 31, 2016 (38,248) $ 28,220 $ 6,452 $ 2,156 $ 40,688 $ 3 16,672 0 (54,923)
Shares, Outstanding, Ending Balance at Dec. 31, 2016   3,963,000 1,593,000 474,000 5,491,000 2,651,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued for public offerings, net of underwriters' fees 292,537         $ 9 292,528    
Stock issued during period (in shares)           9,021,000      
Shares issued under employee stock plans $ 979           979    
Shares issued under employee stock plans (in shares)           199,000      
Repurchase of shares (in shares) 0              
Total offering costs $ (4,228)           (4,228)    
Conversion of preferred stock 77,516 $ (28,220) $ (6,452) $ (2,156) $ (40,688) $ 12 77,504    
Conversion of preferred stock (in shares)   (3,963,000) (1,593,000) (474,000) (5,491,000) 11,521,000      
Warrants exercised 536           536    
Warrants exercised (in shares)           399,000      
Reclassification of warrants 4,607           4,607    
Forfeiture rate adjustment 0           41   (41)
Stock-based compensation 4,378           4,378    
Comprehensive income (loss) (426)             (426)  
Net loss (30,070)               (30,070)
Stockholders' Equity, Ending Balance at Dec. 31, 2017 307,581 $ 0 $ 0 $ 0 $ 0 $ 24 393,017 (426) (85,034)
Shares, Outstanding, Ending Balance at Dec. 31, 2017   0 0 0 0 23,791,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares issued for public offerings, net of underwriters' fees 227,476         $ 3 227,473    
Stock issued during period (in shares)           2,530,000      
Shares issued under employee stock plans $ 2,869           2,869    
Shares issued under employee stock plans (in shares) 583,660         584,000      
Repurchase of shares (in shares) 0                
Total offering costs $ (145)           (145)    
Warrants exercised 76           76    
Warrants exercised (in shares)           17,000      
Stock-based compensation 9,961           9,961    
Comprehensive income (loss) 203             203  
Net loss (61,656)               (61,656)
Stockholders' Equity, Ending Balance at Dec. 31, 2018 $ 486,365 $ 0 $ 0 $ 0 $ 0 $ 27 $ 633,251 $ (223) $ (146,690)
Shares, Outstanding, Ending Balance at Dec. 31, 2018   0 0 0 0 26,922,000